Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you Moneymaker!!!
Management owns 21% of the shares. How many other companies have that kind of management participation?
I get tired of people calling on Lexaria management to buy them out. 'Mr. Bunka should buy shares on the open market'
Hill Street Announces (V)ia Spriza Cannabis Infused Beverages
Toronto, Ontario--(Newsfile Corp. - October 21, 2020) - Hill Street Beverage Company Inc. (TSXV: BEER) ("Hill Street" or the "Company"), is announcing the launch of its highly anticipated Hill Avenue Cannabis Co. (V)ia line-up of cannabis infused beverages. Hill Avenue Cannabis Co. is Hill Street's wholly-owned subsidiary focusing on cannabis infused beverages, drink mixes, tablets, capsules, and leading infusion ingredients intended to create world class Cannabis 2.0 edibles and topicals.
Hill Avenue's new brand (V)ia, meaning "by way of" or "by means of", gives consumers the first truly sophisticated portfolio of adult beverages based on the familiar complex and nuanced taste experiences consumers expect from cask and stainless steel aged fermented grape juice. (V)ia beverages are made from single varietals of grapes grown in France and Spain. (V)ia branded beverages from Hill Avenue Cannabis Co. are created from the same alcohol-free beverages that are available in Hill Street Beverage Co.'s market leading and award-winning Vin(Zero) portfolio of products. (V)ia branded beverages will provide Canadian consumers with the first truly great tasting cannabis infused alternatives to alcohol based on world-class alcohol-free fermented and aged grape juice. Each (V)ia SPRIZA contains less than 30 calories per 150ml serving, allowing consumers to enjoy any social occasion with no regrets from excess calories.
Figure 1: (V)ia SPRIZA Sample Packaging
To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/5205/66553_36881a08b4bccbf2_002full.jpg
Terry Donnelly, Hill Street Chairman and CEO, stated, "We chose these beverages for our (V)ia brand launch as they closely mirror the formats being purchased in the fastest growing segments of adult beverages. (V)ia SPRIZAs are the ideal cannabis infused beverage for any occasion."
"(V)ia SPRIZAs are the first product offerings to be made available under our new Hill Avenue Cannabis Company division. Our planned portfolio of beverages and other edible cannabis products, and our leading edge cannabis ingredient offerings, will permit us to leverage our years of experience in th e CPG space to bring reliable and great tasting products to both cannabis consumers and manufacturers," stated June Nicholson, Hill Street Chief Operating Officer, "It is anticipated that (V)ia SPRIZA Blanc and Rose will be available for sale in cannabis stores and on-line in Ontario beginning in December 2020, with a national rollout in early 2021."
Hill Avenue Cannabis Co. (V)ia SPRIZA Blanc - made from airen grapes from the world renowned La Mancha region of Spain, and used to produce Hill Street's superb Vin(Zero) Brut Blanc. This delightful sparkling SPRIZA Blanc is perfect for any occasion, such as social gatherings or lunch with friends. It has notes of citrus and green apple and a ripe fresh bouquet. Best served chilled or over ice with a slice of lemon.
Hill Avenue Cannabis Co. (V)ia SPRIZA Rose - made from the finest shiraz grapes grown in France, and used to produce Hill Street's renowned Shiraz Rose, th is easy drinking SPRIZA is ideal for parties, afternoon relaxation, sitting on the dock or poolside, with notes of grapefruit, cranberry, and pomegranate, best served chilled or over ice with a slice of orange, grapefruit, or strawberry.
Hill Avenue Cannabis Co. (V)ia SPRIZA beverages have 10mg of THC in each can, providing consumers with an approachable and enjoyable experience that meets the expectations of the most discerning cannabis consumers.
Hill Street Beverage Co. has been an advocate for healthier alternatives to alcohol since its formation in 2008, gaining distribution in retail stores accounting for over two thirds of all grocery sales in Canada, generating increasing online sales in both Canada and the USA, and producing world class private label alcohol free wine for the most demanding retail clients. Its award-winning beverages have been featured in national and international media, and the company has presented its vision for alcohol-free and cannabis-infused beverages at conferences around the world during the past three years. The Company is the co-founder of the Cannabis Beverage Producers' Alliance, which advocates for fair and responsible legislation for beverages including cannabis and hemp extracts. Hill Street's wholly-owned subsidiary, Hill Avenue Cannabis Co., is currently constructing a leading edge cannabis processing facility to produce ingredients for the finest Cannabis 2.0 edible and topical products including infused beverages, drink mixes, tablets, capsules, chocolates, candies, meat, fish, dairy, eggs, sugars, spices, herbs, coffee, tea, and other oral or topical applications of cannabis and hemp extracts.
About Hill Street Beverage Company Inc. (TSX-V:BEER)
Hill Street Beverage Company is a leading and award-winning company focused on alcohol-free beer, wine, and adult-format beverages. Hill Street's brands i nclude Hill Street Craft Brewed Lager, Vin(Zero) and Vintense wines, and have won numerous medals and accolades around the world. Hill Avenue Cannabis, the Company's wholly-owned subsidiary, will produce and sell cannabis-infused adult beverages and other cannabis products with expected distribution at licensed outlets in 2020. Check out Hill Street's award-winning line-up and order product to be delivered straight to your home at www.hillstreetbeverages.com
Yes, and thanks for telling Bunka when it's time to buy!
Hill Street signs deal with Molecule for pot drinks
2020-10-15 09:32 ET - News Release
Also News Release (C-MLCL) Molecule Holdings Inc
Mr. Terry Donnelly of Hill Street Beverage reports
HILL STREET SIGNS AGREEMENT WITH MOLECULE TO PRODUCE CANNABIS INFUSED BEVERAGES
Hill Street Beverage Company Inc. has signed a non-binding term sheet with Molecule Holdings Inc. to produce select cannabis-infused beverages for Hill Avenue Cannabis Co., the wholly owned subsidiary of Hill Street created to manage its business in the legal cannabis segment. The Notice of New Product Introduction to Health Canada was filed on October 1, 2020 for the first beverages to be produced by this partnership. This begins the sixty-day notice period wherein the two companies can begin arranging sales and distribution agreements with provincial regulators and independent retailers.
The three year long agreement will include both formulating and manufacturing beverage products using proprietary infusion technologies provided either by Molecule or Hill Street's previously announced Joint Manufacturing Partnership with Lexaria Biosciences, once Hill Street's Cannabis Processing Facility has been licensed by Health Canada under the Cannabis Act.
Molecule operates a 15,000 sq. ft. state-of-the-art cannabis beverage manufacturing facility located in Lansdowne, Ontario, which has been fully licensed for sales of cannabis 2.0 products including edibles and beverages. It is anticipated that Hill Avenue Cannabis beverages will be available to purchase during the holiday season in select provinces and expanding nationally in 2021.
Terry Donnelly, Chairman & CEO of Hill Street, commented, "We are delighted to expand our manufacturing strategy to include Molecule, given their tremendous knowledge and expertise in beverage formulation, innovation, development, and manufacturing. Their areas of expertise complement ours and we are very much looking forward to working with them to create a portfolio of world class beverages."
Philip Waddington, President & CEO of Molecule Inc., stated, "Hill Street is a renowned leader in the alcohol-free beverage market. We are pleased and excited to be entering into this partnership with such a reputable company, led by an extremely capable team."
Hill Street Beverage Co. has been an advocate for healthier alternatives to alcohol since its launch in 2008, gaining distribution in retail stores accounting for over two thirds of all grocery sales in Canada, generating increasing online sales in both Canada and the USA, and producing world class private label alcohol free wine for the most demanding retail clients. Its award-winning beverages have been featured in national media, and the company has presented its vision for alcohol-free and cannabis-infused beverages at conferences around the world during the past three years. The Company is the co-founder of the Cannabis Beverage Producers' Alliance, which advocates for fair and just legislation for beverages including cannabis and hemp extracts. Hill Street owns a joint manufacturing partnership with Lexaria Bioscience to produce fast-acting, water-soluble, and shelf-stable ingredients made from cannabis extracts for the global Cannabis 2.0 market. Hill Street's wholly owned subsidiary, Hill Avenue Cannabis Co., is currently constructing a leading edge cannabis and hemp oil transformation facility to produce these ingredients, which will be used to create the finest edible and topical products including infused beverages, drink mixes, tablets, capsules, water soluble powder to be used as an ingredient in a multitude of products.
About Hill Street Beverage Company Inc. (TSXV: BEER)
Hill Street Beverage Company is the world's most award-winning company focused on alcohol-free beer, wine, and adult-format beverages. Hill Street's brands include Hill Street Craft Brewed Lager, Vin(Zero), and Vintense wines, and have won numerous medals and accolades around the world. Hill Avenue Cannabis, the Company's wholly-owned subsidiary, will produce and sell cannabis-infused adult beverages and other cannabis products with expected distribution in Canada at licensed outlets in 2020. Check out Hill Street's award-winning line-up and order products to be delivered straight to your home at www.hillstreetbeverages.com.
About Molecule Holdings Inc. (CSE: MLCL)
Molecule works with client-partners to engage in the production of cannabis-infused beverages and edibles. We provide the infrastructure, know-how, technology, and licensing for craft producers to create consumable cannabis products. Molecule's goal is to be the on-ramp for companies wishing to enter into the cannabis beverage and edibles market, but who choose not to go through the significant process of obtaining the required cannabis licences.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.
Yeah, he has to give us the sales figures in a quarterly report anyway so why not some forward guidance?
That's why I say gross revenue if you include everything you don't give away unit costs and any competitive advantage.
Chris Bunka gave us some forward guidance on what the unit sales would be for the powder, I wonder why he doesn't give us some forward guidance on expected gross revenue. We could use some positive spin.
Thanks, Abundance CBD powder sales seem to be our one bright spot with sales growing exponentially with a big chunk of that going to Cannadips.
Do we have a choice now? LOL
BIG Tobacco's Altria Doubling Down On Cannabis
I agree, this is terrible news.
My fear is that they tested it on humans and too high a percentage of people had stomach irritation from ingesting nicotine and DehydraTECH or it's just simply no better than the technology they're using now with ON! pouches.
Kelowna, British Columbia - October 9, 2020 - Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms updates the status of the business relationship between Altria Ventures Inc. ("Altria") and Lexaria Nicotine LLC ("Lexaria Nicotine").
Altria now has non-exclusive licence rights to use DehydraTECH TM for both the US and worldwide markets under a predefined royalty structure payable to Lexaria Nicotine. Altria owns 16.67% of the equity of Lexaria Nicotine in connection with Altria's funding of Lexaria's nicotine R&D program in 2019. Lexaria Bioscience Corp. owns the remaining 83.33% equity of Lexaria Nicotine. Altria holds one seat on the Board of Directors of Lexaria Nicotine and has no ownership or board representation of Lexaria Bioscience Corp.
Altria has not exercised its First Warrant Tranche (as such term is defined in the Warrant and Option Agreement dated as of January 15, 2019 among Lexaria, its majority-owned subsidiary Lexaria Nicotine LLC and Altria) to invest a further staged payment into Lexaria Nicotine and that warrant therefore expired along with Altria's former exclusive access to DehydraTECH for the US market, at 11:59 PM on October 8, 2020.
"The research program initiated in 2019 with Altria significantly advanced our understanding of our patented DehydraTECH drug delivery technology and indirectly led to additional advancements we are already exploiting in other market sectors," said Chris Bunka, CEO of Lexaria. "We have since entered a R&D framework agreement with an international leader in the nicotine market and look forward to additional developments in advancing reduced-risk methods of oral nicotine delivery through our newly strengthened ability to serve the US market."
On October 22, 2019, the U.S. Food and Drug Administration ("FDA") issued its first-ever modified risk tobacco product ("MRTP") ruling related to eight smokeless tobacco products designed for oral use. The FDA allowed claims for these products that using these products "instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." Lexaria strongly supports the use of orally-delivered nicotine products as a sensible alternative to combusted tobacco and believes DehydraTECH will play an important role in this alternative.
The 2019 R&D program was initiated to evaluate oral nicotine delivery performance of an earlier 2018 DehydraTECH oral nicotine formulation . The primary results related to the early-stage DehydraTECH formulation were that:
- It demonstrated acceptable chemical and microbiological stability;
- It was well tolerated in a 7-day, repeat-dose acute toxicology study in rats with no test article-related effects on survival, macroscopic findings, or organ weights and no test article-related histopathological tissue findings;
- It created no issues with throat burn and irritation in oral pouch and chew formats at standard commercial doses upon small scale sensory analysis in humans; and
- It demonstrated formation of a unique mixture of nanoparticles without formation of a covalently linked, new molecular entity construct upon molecular characterization by Canada's National Research Council (NRC); and is therefore not believed to be preclusive of Premarket Tobacco Product Application ("PMTA") applicability in this respect.
Lexaria continues to advance its R&D programs and showcase its advanced technology to tobacco, nicotine and pharmaceutical companies and continuously seeks to expand its portfolio and calibre of research collaborators and commercial partners.
There is no good news, so I expect the bad news will be out after the close today. Disappointing for sure!
It's my understanding that Altria can't buy out Lexaria Nicotine until they have an understanding of what sales will be so that they can properly value the company. So I think probably 2 years of sales to establish a true market value.
Altria will announce that they're moving ahead with the agreement and will present a number of oral nicotine products that they have already developed and are applying for approval to sell.
Because they don't want to tip their hand to competitors. Everything is buying done under the tightest security. Just look at Altria's stealth takeover of Cannadips (Boldt Runners). Altria put 3 of its top (ex?)executives in charge and arranged the financing through a straw buyer. They don't want anyone to know that they intend to be a major player in the CBD market just like they don't want anyone to know their moves in the oral nicotine market.
I believe Altria is deep into product development and marketing development with DehydraTECH. The next announcement will be to showcase the products they are submitting for approval and this could come on Oct. 8th. I expect a wide range of nicotine products marketed as smoking-cessation products (gums, lozenges, powders). In addition, there will be ON! Pouches powered by DyhdraTECH and other recreational products.
That is their plan to uplist and then do a financing at a higher price.
Yes, isn't it great! Increasing revenues mean acceptance of the technology and I believe it will soon become common knowledge that DehydraTECH is the best and most cost-effective techs out there for a myriad of products. Hold on for the ride, it's going to be wild.
LXRP chart is looking very nice, a bull hammer marked the bottom and we've broken out of the downtrend on 3 days of heavy volume, a golden cross is in the very near future.
It's important and interesting that the vast majority of trades are in the US. Just wait till my fellow Canadians wake up! LOL
Yes, the volume in the last 2 days speaks.
OK, the release has finally appeared on stockwatch.com, must have been my platform was late to the party.
Because it wasn't released to the stock exchanges. I don't see any news releases under LXX or LXRP. They're not reaching the people who count.
No, I mean the 4.4 million + the 56 million verbal. The majority must be for Cannadips.
I don't understand why the powder sales didn't rate a news release.
Well, it's a 'make or break date' for me, cuz if they don't move ahead on the 8th, I'm going to snap! LOL
$100 says Nexleaf will never get a patent for this 'patent pending technology utilizes food-grade emulsifiers already approved by Health Canada'
Because they are readily available emulsifiers this technology is not patentable. Others have tried and failed.
Hello DehydraTECH!
Chocolates here: https://1906newhighs.com/products/love/
Nice! They have some of the best marketing people shepherding this company to success and we know that they didn't land here from Altria by accident.
Thanks again, I think the THC pouches with DehydraTECH and the combi-pouches will be selling like hotcakes!
I didn't know they were making THC pouches, thanks.